6-(Methylthio)pyrimido[5,4-d]pyrimidin-4(1H)-one, 95.0%, 250mg

2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

3,5-Dinitro-4-hydroxyphenylacetic acid, 1g

1-(4-Trifluoromethylphenyl)-2-pyrrolidinone, 97.0%, 1g

(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride, 95%, 10g

1,2'-Dinaphthylamine>98.0%(HPLC)(N)5g

3',5'-dichloro-3-(3,5-dimethylphenyl)propiophenone, 97.0%, 1g

2-(4-Bromophenyl)-5-phenyl-1,3,4-oxadiazole, 97.0%, 100mg

Microliter syringe MICROLITER® series 700 Tip type 2, 25 µl, 702 N, 1 piece

N-(3-Aminopropyl)-N-methylcarbamic acid tert-butylester, 95.0%, 250mg

2-Chloro-4-hydroxy-5-nitrobenzoic acid, 95.0%, 1g

2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-AMINE HCL, 95.0%, 1g

tert-Butyl Ethyl Ether>95.0%(GC)5mL